CompuMed claims digital advance

Article

Bone densitometry firm CompuMed announced last week that it has successfully acquired images using both dual-energy x-ray absorptiometry and amorphous silicon x-ray detectors. The Manhattan Beach, CA, firm believes that being able to acquire such images

Bone densitometry firm CompuMed announced last week that it has successfully acquired images using both dual-energy x-ray absorptiometry and amorphous silicon x-ray detectors. The Manhattan Beach, CA, firm believes that being able to acquire such images will help the company in its development of Digital OsteoView 2000, a device designed to detect both osteoporosis and arthritis.

CompuMed scientists working with researchers at the University of Massachusetts used amorphous silicon flat-panel detectors licensed from Varian Associates, with whom CompuMed has an OEM agreement (SCAN 1/8/97). CompuMed plans to file for 510(k) clearance for Digital OsteoView 2000 later this year.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.